Collaboration
Proteoformics stands at the forefront of advancing immunotherapy by focusing on the discovery of novel and unique therapeutic targets. Through our collaborative approach, we harness the collective expertise of the scientific community, industry partners, and innovative thinkers to pinpoint precise targets, particularly for solid tumors.
Areas of Collaboration
Our alliance with leading pharmaceutical and biotechnological firms fast-tracks the transition from discovery to real-world therapeutic applications.
Industry Partnerships
By connecting with top-tier research institutions, we're ensuring our target discovery methodologies remain state-of-the-art and scientifically robust.
Academic Collaborators
Collaboration with emerging startups infuses our processes with fresh insights and revolutionary techniques, nurturing a culture of groundbreaking innovation.
Startup Engagement
